Vimarsana
Biggest News Aggregation in the World

Page 33 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roivant Sciences Today - Breaking & Trending Today

Roivant to Report Financial Results for the Second Quarter - Vimarsana News

Roivant to Report Financial Results for the Second Quarter

BASEL, LONDON, and NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and...

The American Story: The Biography of Vivek Ramaswamy - Vimarsana News

The American Story: The Biography of Vivek Ramaswamy

Vivek Ramaswamy is an American entrepreneur, author, and presidential candidate. Ramaswamy is a rising star in the Republican Party and is seen as a potential challenger to Donald Trump for the 2024 Republican presidential nomination

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2023, and Provide Business Update on Monday, November 13, 2023 - Vimarsana News

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2023, and Provide Business Update on Monday, November 13, 2023

BASEL, LONDON, and NEW YORK, Oct. 30, 2023 -- Roivant today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, November 13, 2023, to report its financial...

CITY WHISPERS: Labour council debt is a downer for THG's Matt Moulding - Vimarsana News

CITY WHISPERS: Labour council debt is a downer for THG's Matt Moulding

Warrington Council sought to offset Government-imposed budget cuts by investing in local projects, including a business park housing THG's head office, owned by Moulding.

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars? - Vimarsana News

Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?

The three companies are spending big on IBD therapies.

Source: fool.com